NOVO NORDISK A/S (NONOF) Financials
NONOF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 46.6 billion | 30.8 billion |
| 2023-09-30 | 42.6 billion | 29.4 billion |
| 2023-06-30 | 41.0 billion | 27.8 billion |
| 2023-03-31 | 36.6 billion | 24.9 billion |
NONOF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.0 billion | 3.5 billion |
| 2023-09-30 | 4.3 billion | -464.8 million |
| 2023-06-30 | 3.1 billion | -663.8 million |
| 2023-03-31 | 3.7 billion | -974.5 million |
NONOF Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 3.3 billion |
| 2023-09-30 | 3.2 billion |
| 2023-06-30 | 2.8 billion |
| 2023-03-31 | 2.9 billion |
NONOF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 4.5 billion | - | 847.7 million |
| 2023-09-30 | 6.7 billion | - | - |
| 2023-06-30 | 5.3 billion | - | - |
| 2023-03-31 | 4.1 billion | - | - |
NONOF Shares Outstanding
NONOF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 2.4 billion | 1.5 billion | 215.6 million | 2.5 billion |
| 2023-09-30 | 1.5 billion | 1.2 billion | 178.1 million | 1.8 billion |
| 2023-06-30 | 1.0 billion | 1.0 billion | 156.6 million | 2.1 billion |
| 2023-03-31 | 702.9 million | 985.0 million | 156.8 million | 1.8 billion |
NONOF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 9.8 billion | 1.5 billion |
| 2023-09-30 | 8.3 billion | 1.4 billion |
| 2023-06-30 | 7.9 billion | 1.1 billion |
| 2023-03-31 | 7.8 billion | 1.2 billion |
NONOF
Price: $132.60
Forward Dividend Yield: 1.41%
Payout Ratio: 70.12%
Dividend Per Share: 1.87 USD
Earnings Per Share: 2.87 USD
P/E Ratio: 45.13
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 572.5 billion
Average Dividend Frequency: 2
Years Paying Dividends: 16
DGR3: 30.00%
DGR5: 30.00%
DGR10: 30.00%